Evolent Historical Balance Sheet
EVH Stock | USD 12.21 0.96 8.53% |
Trend analysis of Evolent Health balance sheet accounts such as Total Current Liabilities of 708 M or Total Stockholder Equity of 706.1 M provides information on Evolent Health's total assets, liabilities, and equity, which is the actual value of Evolent Health to its prevalent stockholders. By breaking down trends over time using Evolent Health balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Evolent Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Evolent Health is a good buy for the upcoming year.
Evolent Health Inventory |
|
Evolent |
About Evolent Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Evolent Health at a specified time, usually calculated after every quarter, six months, or one year. Evolent Health Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Evolent Health and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Evolent currently owns. An asset can also be divided into two categories, current and non-current.
Evolent Health Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Evolent Health assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Evolent Health books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Evolent Health balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Evolent Health are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from Evolent Health's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Evolent Health current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.As of now, Evolent Health's Net Debt is increasing as compared to previous years. The Evolent Health's current Accounts Payable is estimated to increase to about 48.9 M, while Total Stockholder Equity is projected to decrease to under 706.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 323.3M | 356.3M | 600.5M | 630.6M | Total Assets | 1.4B | 1.8B | 2.7B | 2.8B |
Evolent Health balance sheet Correlations
Click cells to compare fundamentals
Evolent Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evolent Health balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.5B | 1.4B | 1.4B | 1.8B | 2.7B | 2.8B | |
Other Current Liab | 129.2M | 319.9M | 323.3M | 356.3M | 600.5M | 630.6M | |
Total Current Liabilities | 192.8M | 401.8M | 445.5M | 433.4M | 674.2M | 708.0M | |
Total Stockholder Equity | 922.4M | 619.6M | 693.6M | 859.4M | 1.1B | 706.1M | |
Property Plant And Equipment Net | 157.3M | 144.0M | 131.6M | 136.9M | 90.2M | 84.7M | |
Net Debt | 267.8M | 19.3M | 14.2M | 287.9M | 452.0M | 474.6M | |
Retained Earnings | (252.0M) | (589.2M) | (626.8M) | (606.2M) | (719.2M) | (683.2M) | |
Accounts Payable | 37.5M | 32.0M | 96.1M | 57.2M | 48.2M | 48.9M | |
Cash | 101.0M | 340.5M | 266.3M | 188.2M | 192.8M | 176.4M | |
Non Current Assets Total | 1.3B | 824.1M | 895.5M | 1.3B | 2.0B | 2.1B | |
Non Currrent Assets Other | 8.3M | 7.3M | 13.0M | 32.3M | 33.0M | 34.7M | |
Other Assets | 92.0M | 186.5M | 52.4M | 32.3M | 33.0M | 60.4M | |
Cash And Short Term Investments | 101.0M | 340.5M | 266.3M | 188.2M | 192.8M | 196.3M | |
Net Receivables | 77.4M | 124.4M | 130.6M | 254.7M | 446.7M | 469.1M | |
Common Stock Shares Outstanding | 82.4M | 84.9M | 86.1M | 93.7M | 111.3M | 70.4M | |
Liabilities And Stockholders Equity | 1.5B | 1.4B | 1.4B | 1.8B | 2.7B | 2.8B | |
Other Current Assets | 200.5M | 104.6M | 127.1M | 35.2M | 44.1M | 73.6M | |
Other Stockholder Equity | 1.2B | 1.2B | 1.3B | 1.5B | 1.8B | 1.9B | |
Total Liab | 569.0M | 750.6M | 725.8M | 957.9M | 1.6B | 1.7B | |
Total Current Assets | 228.8M | 546.1M | 524.0M | 478.1M | 683.7M | 354.3M | |
Intangible Assets | 308.5M | 268.1M | 279.8M | 442.8M | 752.0M | 789.6M | |
Other Liab | 13.7M | 455.2M | 6.9M | 55.4M | 63.8M | 71.7M | |
Current Deferred Revenue | 19.8M | 14.3M | 11.9M | 5.8M | 6.0M | 5.7M | |
Short Term Investments | 1.8M | 3.9M | 75.7M | 14.5M | 13.8M | 25.7M | |
Non Current Liabilities Total | 376.2M | 348.8M | 280.3M | 524.4M | 938.4M | 985.3M | |
Inventory | 78.5M | (150.1M) | (445.1M) | (308.2M) | (415.9M) | 1.05 | |
Property Plant And Equipment Gross | 157.3M | 144.0M | 250.7M | 287.4M | 248.7M | 139.8M | |
Accumulated Other Comprehensive Income | (234K) | (278K) | (362K) | (1.2M) | (1.3M) | (1.3M) | |
Short Term Debt | 6.3M | 41.3M | 14.1M | 14.2M | 19.5M | 18.5M | |
Property Plant Equipment | 85.2M | 86.2M | 81.4M | 87.9M | 101.1M | 60.1M | |
Net Tangible Assets | 41.8M | (3.2M) | (12.4M) | (306.1M) | (275.5M) | (261.8M) | |
Long Term Debt | 293.7M | 263.3M | 215.7M | 413.0M | 597.0M | 626.9M | |
Good Will | 572.1M | 354.7M | 426.3M | 722.8M | 1.1B | 707.6M | |
Common Stock Total Equity | 846K | 859K | 908K | 1.0M | 1.2M | 791.4K | |
Deferred Long Term Liab | 1.9M | 728K | 1.4M | 4.7M | 4.3M | 4.1M | |
Long Term Investments | 139.4M | 17.4M | 5.5M | 4.5M | 4.9M | 4.7M | |
Common Stock | 846K | 859K | 908K | 1.0M | 1.2M | 839.2K | |
Retained Earnings Total Equity | (252.0M) | (589.2M) | (626.8M) | (606.2M) | (545.5M) | (518.3M) |
Currently Active Assets on Macroaxis
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 21.554 | Quarterly Revenue Growth 0.216 | Return On Assets 0.0073 | Return On Equity (0.06) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.